4-144001260-T-G
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_002100.6(GYPB):āc.61A>Cā(p.Ser21Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000341 in 1,612,980 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: š 0.00020 ( 2 hom., cov: 32)
Exomes š: 0.000017 ( 0 hom. )
Consequence
GYPB
NM_002100.6 missense
NM_002100.6 missense
Scores
2
4
11
Clinical Significance
Conservation
PhyloP100: -0.950
Genes affected
GYPB (HGNC:4703): (glycophorin B (MNS blood group)) Glycophorins A (GYPA) and B (GYPB) are major sialoglycoproteins of the human erythrocyte membrane which bear the antigenic determinants for the MN and Ss blood groups. GYPB gene consists of 5 exons and has 97% sequence homology with GYPA from the 5' UTR to the coding sequence encoding the first 45 amino acids. In addition to the M or N and S or s antigens, that commonly occur in all populations, about 40 related variant phenotypes have been identified. These variants include all the variants of the Miltenberger complex and several isoforms of Sta; also, Dantu, Sat, He, Mg, and deletion variants Ena, S-s-U- and Mk. Most of the variants are the result of gene recombinations between GYPA and GYPB. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Jan 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.051583707).
BS2
High Homozygotes in GnomAd4 at 2 BG gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GYPB | NM_002100.6 | c.61A>C | p.Ser21Arg | missense_variant | 2/5 | ENST00000502664.6 | NP_002091.4 | |
GYPB | XM_011531903.3 | c.61A>C | p.Ser21Arg | missense_variant | 2/5 | XP_011530205.1 | ||
GYPB | XM_011531904.4 | c.34A>C | p.Ser12Arg | missense_variant | 3/6 | XP_011530206.1 | ||
GYPB | NM_001304382.1 | c.-18A>C | 5_prime_UTR_variant | 3/6 | NP_001291311.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GYPB | ENST00000502664.6 | c.61A>C | p.Ser21Arg | missense_variant | 2/5 | 1 | NM_002100.6 | ENSP00000427690.1 | ||
GYPB | ENST00000504951.6 | n.*47A>C | non_coding_transcript_exon_variant | 3/7 | 1 | ENSP00000421974.2 | ||||
GYPB | ENST00000504951.6 | n.*47A>C | 3_prime_UTR_variant | 3/7 | 1 | ENSP00000421974.2 |
Frequencies
GnomAD3 genomes AF: 0.000198 AC: 30AN: 151558Hom.: 2 Cov.: 32
GnomAD3 genomes
AF:
AC:
30
AN:
151558
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000837 AC: 21AN: 250968Hom.: 0 AF XY: 0.0000663 AC XY: 9AN XY: 135658
GnomAD3 exomes
AF:
AC:
21
AN:
250968
Hom.:
AF XY:
AC XY:
9
AN XY:
135658
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000171 AC: 25AN: 1461304Hom.: 0 Cov.: 31 AF XY: 0.0000124 AC XY: 9AN XY: 726966
GnomAD4 exome
AF:
AC:
25
AN:
1461304
Hom.:
Cov.:
31
AF XY:
AC XY:
9
AN XY:
726966
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000198 AC: 30AN: 151676Hom.: 2 Cov.: 32 AF XY: 0.000202 AC XY: 15AN XY: 74184
GnomAD4 genome
AF:
AC:
30
AN:
151676
Hom.:
Cov.:
32
AF XY:
AC XY:
15
AN XY:
74184
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
1
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
6
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 03, 2024 | The c.61A>C (p.S21R) alteration is located in exon 2 (coding exon 2) of the GYPB gene. This alteration results from a A to C substitution at nucleotide position 61, causing the serine (S) at amino acid position 21 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
.;T;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Uncertain
D;D;D
M_CAP
Benign
T
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
PROVEAN
Pathogenic
D;D;.
REVEL
Benign
Sift
Uncertain
D;D;.
Sift4G
Pathogenic
D;D;.
Vest4
MutPred
Loss of glycosylation at T23 (P = 0.0184);Loss of glycosylation at T23 (P = 0.0184);Loss of glycosylation at T23 (P = 0.0184);
MVP
MPC
0.022
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at